ghk-cu target Neurogan The natural blue GHK-Cu Copper Peptide Face &

Use only as directed by a qualified healthcare professional

Treatment of 24-month-old mice (equivalent to elderly humans) with NNMT inhibitors rescued age-related deficits in muscle stem cell activity

While it has been in research for over 20 years, it has recently gained a second life thanks to the massive public interest in peptide therapy and the rise of GLP-1 medications.

[1] [2] These results should be interpreted in context: they reflect specific dose groups within obesity cohorts and may not apply across all doses, populations, or indications such as type 2 diabetes

Le taux de glutathion intracellulaire diminue avec l'ge

This population faces a higher risk of B12 deficiency which may be further increased by use of acid-reducing medications